Skip to main content
Clinical Trials/NCT04969042
NCT04969042
Recruiting
Phase 1

Efficacy of Closed-loop Functional Spinal Cord Stimulation on Walking Rehabilitation in Patients With Spinal Cord Injury

Luming Li1 site in 1 country10 target enrollmentAugust 1, 2021

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Spinal Cord Injuries
Sponsor
Luming Li
Enrollment
10
Locations
1
Primary Endpoint
Weight Bearing Capacity
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this experiment is to evaluate the efficacy of Closed-loop Functional Spinal Cord Stimulation on Walking Rehabilitation in Patients after Spinal Cord Injury

Detailed Description

The whole course will last around 12 months, during which there will be: Pre-implant evaluations and standard rehabilitation (6-10 weeks), Stimulator implantation and stimulation optimization (4-8 weeks), Rehabilitation training with stimulation (6 months). At the end of the protocol, the study aims to make the patients walk better and faster.

Registry
clinicaltrials.gov
Start Date
August 1, 2021
End Date
August 1, 2027
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Luming Li
Responsible Party
Sponsor Investigator
Principal Investigator

Luming Li

Director of National Engineering Laboratory for Neuromodulation

Tsinghua University

Eligibility Criteria

Inclusion Criteria

  • Age 18\~70
  • Spinal cord injury staging(AIS) A,B,C or D
  • Level of lesion is T10 and above
  • Distance between lesion and conus \>60mm
  • Injured Time \> 3 months
  • Capable of participating rehabilitation program
  • Agree to comply with all conditions of the study and to attend all required study training and visits

Exclusion Criteria

  • With Obvious psychiatric disorder that cannot complete relevant questionaires
  • Cognitive impairment
  • Severe autonomic reflex disorder
  • Severe muscle atrophy and joint contracture
  • Cannot participate in spinal cord stimulation surgery or follow-up visits
  • Life expectancy less than 12 months
  • Abnormal blood or other physiological examinations that cannot conduct surgery, such as blood coagulation disorder or kidney/liver abnormalities
  • Uncontrollable hypertension, heart diseases, respiratory diseases or took related medicine in last 3 months
  • Unsuitable candidates in PI's perspective

Outcomes

Primary Outcomes

Weight Bearing Capacity

Time Frame: Change from Baseline to the 8 month after implantation.

Weight-bearing capacity (WBC) is an important outcome to monitor and particularly relevant in patients with severe motor impairments who cannot walk independently. The investigators use LPG HUBER360 to examine subjects' weight bearing capacity

WISCI III

Time Frame: Change from Baseline to the 8 month after implantation.

A Common method used to evaluate SCI patient's walking capability in clinical setting

10-metre Walking Test 10-metre Walking Test 10-metre Walking Test 10 meter wlaking

Time Frame: Change from Baseline to the 8 month after implantation.

10-Meter Walk Test (10MWT) is commonly used to measure walking speeds during two conditions: a self-selected normal speed, and a self-selected 'faster-than-normal' speed.

Study Sites (1)

Loading locations...

Similar Trials